SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.9% | 14.4% | 12.2% | 13.3% | 13.3% | 5.8% | 5.2% | 21.0% | 153.3% | 77.5% | 134.2% | – | |
| 87.1% | 85.6% | 87.8% | 86.7% | 86.7% | 94.2% | 94.8% | 79.0% | -53.3% | 22.5% | -34.2% | 100.0% | |
| 37.0% | 27.6% | 22.5% | 0.8% | 0.8% | 0.5% | 1.2% | 15.2% | 91.9% | 23.7% | 107.6% | 62.8% | |
| 107.6% | 58.7% | 40.9% | 25.4% | – | – | – | – | – | – | – | – | |
| 144.5% | 85.9% | 63.7% | 26.5% | 26.5% | 2.0% | 6.4% | 28.1% | 331.2% | 63.6% | 272.5% | 120.3% | |
| -57.4% | -0.4% | 24.0% | 60.1% | 60.1% | 92.3% | 88.4% | 50.9% | -384.5% | -12.0% | -306.7% | -40.0% | |
| 1.4% | 0.7% | 0.5% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.2% | 0.1% | 0.2% | 0.6% | |
| -55.0% | -0.2% | 23.2% | 60.6% | 60.6% | 60.8% | 58.3% | 51.2% | -203.1% | -11.9% | -11.9% | -29.0% | |
| -6.9% | 2.2% | 4.9% | 7.8% | 7.8% | 14.3% | 18.3% | 11.2% | -70.9% | -6.8% | -23.9% | 45.1% | |
| -38.1% | -7.2% | 9.7% | 52.7% | 33.2% | 46.5% | 40.0% | 40.0% | -132.2% | -5.0% | 12.0% | -38.0% | |
| -48.2% | 3.6% | 24.0% | 61.1% | 61.0% | 92.4% | 89.0% | 57.3% | -293.0% | -12.3% | 14.8% | -8.7% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.